Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.71% Nasdaq Up1.29%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS

95.32 Feb 5, 4:00PM EST

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 783,431   540,957   386,800  
Cost of Revenue93,140  64,437  45,059  
Gross Profit 690,291   476,520   341,741  
Operating Expenses
Research Development137,421  98,394  81,915  
Selling General and Administrative308,176  226,766  172,767  
Non Recurring13,486  722   -  
Others382   -   -  
Total Operating Expenses459,465   -   -  
Operating Income or Loss 230,826   150,638   87,059  
Income from Continuing Operations
Total Other Income/Expenses Net(370)(923)(3,139)
Earnings Before Interest And Taxes230,456  149,715  83,920  
Interest Expense788  704  606  
Income Before Tax229,668  149,011  83,314  
Income Tax Expense54,353  51,981  (211,852)
Minority Interest -   -   -  
Net Income From Continuing Ops175,315  97,030  295,166  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 175,315   97,030   295,166  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 175,315   97,030   295,166  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.